NEW YORK – Genomic analysis company SeqOne

纽约——基因组分析公司SeqOne

Genomics

基因组学

said last week that it has raised €20 million ($22.7 million) in an oversubscribed growth funding round.

上周表示，它在一场超额认购的增长资金轮中筹集了2000万欧元（2270万美元）。

The round was led by new investor Supernova Invest, with support from existing investors Elaia, Omnes, and Mérieux Equity Partners, SeqOne said.

Supernova Invest 新投资者领投了这一轮融资，现有投资者 Elaia、Omnes 和 Mérieux Equity Partners 也给予了支持，SeqOne 表示。

With the money raised, Montpellier, France-based SeqOne said it plans to accelerate its growth strategies, particularly through global expansion, US market acceleration, and strategic acquisitions.

法国蒙彼利埃的SeqOne表示，公司计划利用筹集到的资金加速其增长战略，特别是通过全球扩张、美国市场加速和战略性收购。

'This new capital injection not only empowers us to scale our international operations, particularly with our US launch, and to further enhance our technological leadership, but it also fortifies our financial foundations, ensuring our customers can depend on us as a steadfast partner for years to come,' SeqOne CEO Martin Dubuc said in a statement.

SeqOne首席执行官马丁·杜布克在一份声明中表示：“这笔新的资本注入不仅使我们能够扩大国际业务规模，特别是支持我们在美国的推出，并进一步巩固我们的技术领先地位，同时也加强了我们的财务基础，确保我们的客户能够依赖我们作为他们未来多年的坚定合作伙伴。”

'Our goal is to equip every molecular laboratory with the most advanced, intuitive, and reliable genomic analysis solutions.'.

“我们的目标是为每个分子实验室配备最先进的、直观的、可靠的基因组分析解决方案。”

A 2017 spinout from Centre Hospitalier Universitaire de Montpellier, SeqOne

2017年从蒙彼利埃大学中心医院分拆出来的SeqOne

raised €20M

筹集了2000万欧元

in Series A funding in 2022. The company has previously inked partnerships with

在2022年的A轮融资中。该公司此前已签署了合作伙伴关系

MGI Tech

华大智造

and

和

Oxford Nanopore Technologies

牛津纳米孔技术公司

for genomics analysis and interpretation.

用于基因组学分析和解释。